Quote | XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:XOMAP)
Last: | $26.34 |
---|---|
Change Percent: | 0.57% |
Open: | $25.52 |
Close: | $26.19 |
High: | $26.34 |
Low: | $25.13 |
Volume: | 2,053 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:XOMAP)
2024-07-02 09:00:25 ET XOMA Corp (XOMAP) declaring a stock dividend of $0.53906 per share on Ex-Date : July 03, 2024. Shareholders on record as of July 03, 2024 are eligible for the dividend. The payment date is scheduled for July 15, 2024, and the declaration was officially made on...
2024-06-29 02:31:45 ET Summary XOMA Corporation operates as a biotechnology royalty aggregator, acquiring economic rights to milestones and royalties from approved or clinical-stage drugs. XOMA’s diverse IP portfolio spans various therapeutic areas, including oncology, immu...
Message Board Posts | XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:XOMAP)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock Company Name:
XOMAP Stock Symbol:
NASDAQ Market:
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock Website:
2024-07-02 09:00:25 ET XOMA Corp (XOMAP) declaring a stock dividend of $0.53906 per share on Ex-Date : July 03, 2024. Shareholders on record as of July 03, 2024 are eligible for the dividend. The payment date is scheduled for July 15, 2024, and the declaration was officially made on...
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals’ recent sale of its Priority Revie...
2024-05-26 12:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...